Market Currents
Compugen (CGEN), which last week signed a big collaboration deal with Pfizer (PFE), is up 34%...
-
Monday, December 28, 2009, 9:05 AM ETCompugen (CGEN), which last week signed a big collaboration deal with Pfizer (PFE), is up 34% premarket after announcing the discovery and experimental validation of a new drug target for multiple epithelial tumors, whose carcinomas account for approximately 85% of all cancers.
Other date
Latest Articles
